Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
PGE $300 million at-the-market offering
The common stock is listed on the NYSE
Morgan Stanley Bank 3(a)(2) program and inaugural $1.5 billion offering
We advised Morgan Stanley Bank on its 3(a)(2) program and senior notes offering
Japan Finance Organization for Municipalities $1 billion takedown offering
The 4.125% notes are due 2028
IDEAYA Biosciences $201 million equity offering
The common stock is listed on the Nasdaq Global Select Market
Bed Bath & Beyond chapter 11 filing
We are advising the ABL agent in connection with the restructuring
Canada $4 billion global bond offering
The investment-grade bonds are due 2028
Morgan Stanley $6 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering
Bank of America $8.5 billion fixed-to-floating-rate notes
The investment-grade notes are due 2029 and 2034
Pilgrim’s Pride $1 billion notes offering
The investment-grade notes are due 2033
Diagnósticos da América R$1.7 billion equity offering
The common shares and the warrants are listed on the São Paulo Stock Exchange